Beth C. Seidenberg, Director of Sagimet Biosciences SGMT, has filed 23 purchases and 5 sales on the open market. Over the past 12 months that comes to a net purchase of $1000K. The latest trade was on 06/12.

Beth C. Seidenberg

Director

Company: Sagimet Biosciences SGMT
First filing: 23/02/09

Trades: 85 trades
Buys / sales: 23 / 5
12-month net buying: $1M
Last trade: 06/12

Trading activity

Transactions

	Trade type
Kyverna TherapeuticsKYTX	Open-market buy	25/12/18	25/12/22	133,333 sh	$7.50	$999,997.5	+18.1%
VERA	Open-market sale10b5-1 plan	24/10/28	24/10/30	15,000 sh2 trades	$48.03avg.	$720,459.06	−10.2%
VERA	Open-market sale10b5-1 plan	24/09/18–24/09/19	24/09/20	16,476 sh3 trades	$42.26avg.	$696,288.9	No record
Sagimet BiosciencesSGMT	Open-market buy	23/07/18	23/07/20	46,875 sh	$16.00	$750,000	No record
	Open-market buy	23/05/09	23/05/11	1,310,000 sh2 trades	$18.00avg.	$23,580,000	No record
Vera TherapeuticsVERA	Open-market buy	23/03/30	23/04/03	2,300 sh	$7.24	$16,652	+0.1%
Vera TherapeuticsVERA	Open-market buy	23/03/28	23/03/30	23,908 sh	$7.24	$173,093.92	+1.2%
VERA	Open-market buy	23/03/24–23/03/27	23/03/28	3,466 sh2 trades	$7.24avg.	$25,093.84	+0.2%
VERA	Open-market buy	23/03/17–23/03/20	23/03/21	89,297 sh2 trades	$7.14avg.	$637,167.32	+4.9%
VERA	Open-market buy	23/03/15–23/03/16	23/03/17	92,941 sh2 trades	$7.10avg.	$659,937.01	+5.3%
Vera TherapeuticsVERA	Open-market buy	23/03/10	23/03/14	48,003 sh	$7.16	$343,701.48	+2.8%
Vera TherapeuticsVERA	Open-market buy	23/03/03	23/03/07	1,000 sh	$7.25	$7,250	+0.1%
VERA	Open-market buy	23/03/01–23/03/02	23/03/03	23,478 sh2 trades	$7.24avg.	$169,981.72	+1.4%
Vera TherapeuticsVERA	Open-market buy	23/02/23	23/02/27	200 sh	$7.24	$1,448	+0.0%
Vera TherapeuticsVERA	Open-market buy	23/02/13	23/02/15	10,072 sh	$7.20	$72,518.4	+0.6%
Vera TherapeuticsVERA	Open-market buy	23/02/09	23/02/13	400 sh	$7.25	$2,900	+0.0%
VERA	Open-market buy	23/02/03–23/02/08	23/02/09	311,078 sh4 trades	$7.10avg.	$2,209,588.2	+23.2%